The PrognosticRole of Tumor Marker CA-125 in B-Cell

Abstract

Background: B-cell non-Hodgkin’s lymphoma (NHL) is a common malignancy of lymphoid tissues. Different types of NHL show various behaviors, prognoses, and responses to treatment. Evaluation of disease activity in NHL can be helpful in managing and even increasing the patient’s survey.

Description

Keywords

Citation

Endorsement

Review

Supplemented By

Referenced By